AzTrials
AzTrials

DementiaNCT03175822

Effects of Visual Art Training on Dementia

A study testing Visual Arts Training in people with Dementia, run by York University at 1 site in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of the proposed study is to better understand what benefits visual art has on reducing problematic symptoms in dementia patients, including those with Alzheimer's disease. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Dementia
What is being tested?
Visual Arts Training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
83 participants
Where
1 siteCanada
Study dates
1 Sep 2017to 15 Jun 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Dementia

Who cannot join

  • Inability to participate in the art training program due to physical or cognitive limitations

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • Alzheimer's Society of York Region

    Aurora, Ontario

Other trials in Canada

About this study

The purpose of the proposed study is to better understand what benefits visual art has on reducing problematic symptoms in dementia patients, including those with Alzheimer's disease.

Read the detailed description

Participants:

Participants will be residents, attendees and/or members of assisted living locations and/or dementia (or related) day programs. There will be two groups: an art training group and a waitlist control group.

Data Analysis:

  1. For primary measures, t-tests on pre-post difference scores comparing art training and waitlist groups.
  2. For possible confounding effects, tests for confounds related to background factors (socioeconomic status, education level, gender, activity participation).

Procedure:

A randomized controlled trial design will be utilized to assess two groups of dementia patients: an art training experimental group and a structured usual-activity waitlist control group. The experimental group will participate in a visual art training program and the waitlist control group will participate in their usual structured group activities. The waitlist control group will receive the art training program once post-testing is complete. Before, during, and/or after the art programs and/or control activities, participants will be observed and complete assessments.

Conditions
Dementia
Being tested
Visual Arts Training
Medical subject headings
Dementia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Visual Arts TrainingBehavioural

    The art training program has been designed as a drawing program and focuses on basic visual art concepts (the elements [e.g., colour and line] and principles [e.g., proportion and balance] of design). Each week has a different activity and a different focus (one activity per week focusing on one element and principle of design). Each art training program will occur one hour per day, two days per week, for eight weeks. The art training program will take place at the participants' respective dementia care location in an area separate from waitlist control participants and uninvolved clients. All art programs are free for participants.

Study groups in NCT03175822
Study groupRoleWhat they receive
Visual Arts TrainingExperimentalVisual Arts Training
Receives: Behavioral: Visual Arts Training
Waitlist ControlNo interventionWaitlist Control

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in cognition

    Montreal Cognitive Assessment (MoCA; Nasreddine, 2005)

    Measured: baseline up to three weeks prior, and final assessment one to two weeks post-intervention

  2. Change in visual working memory

    Body Part Pointing Test (Stopford et al., 2010)

    Measured: baseline up to three weeks prior, and final assessment one to two weeks post-intervention

  3. Change in auditory working memory

    Digit Span (Weschler, 2008)

    Measured: baseline up to three weeks prior, and final assessment one to two weeks post-intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Jun 2017
  2. Study start1 Sep 2017
  3. Primary completion15 Jun 2018
  4. Study completion15 Jun 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
83 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03175822
Sponsor's protocol ID
YorkU-AD2
Status last verified
Jul 2018
First submitted
24 May 2017
Last updated
24 Jul 2018
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Johnson KG, D'Souza AA, Wiseheart M. Art Training in Dementia: A Randomized Controlled Trial. Front Psychol. 2020 Dec 15;11:585508. doi: 10.3389/fpsyg.2020.585508. eCollection 2020.

    PubMed 33384640

Questions about this trial

What is this clinical trial studying?

A study testing Visual Arts Training in people with Dementia, run by York University at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Jul 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in cognition (time frame: baseline up to three weeks prior, and final assessment one to two weeks post-intervention). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03175822, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Jul 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in